Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets ...Middle East

Gennisium finds a strategic partner with global experience and connections in the pharmaceutical industry to accelerate its development in neonatology. Pierre Fabre strengthens its activities in the field of rare diseases, and more specifically pediatric ones. This partnership paves the...

Hence then, the article about pierre fabre is taking a minority stake via its dedicated investment subsidiary pierre fabre invest in gennisium pharma an innovative company specializing in medicines for premature newborns and niche markets was published today ( Monday 10/10/2022 - 10:08 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets )

Also on site :

• Isomer's Brightening Anti-Aging Duo Is Perfect for Women Over 50, and Shoppers Confirm It's 'So Good'
• How much? NATO chief calls for ‘Ukraine tax’ bigger than members’ economies
• ‘Fatherland’ Review: Pawel Pawlikowski’s Meditation On Postwar Germany Is A Masterclass In Artistic Discipline – Cannes Film Festival